A detailed history of Prossimo Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Prossimo Advisors, LLC holds 12,828 shares of PFE stock, worth $322,367. This represents 0.27% of its overall portfolio holdings.

Number of Shares
12,828
Previous 24,249 47.1%
Holding current value
$322,367
Previous $678,000 45.28%
% of portfolio
0.27%
Previous 0.61%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$27.7 - $31.39 $316,361 - $358,505
-11,421 Reduced 47.1%
12,828 $371,000
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $612,529 - $717,770
24,249 New
24,249 $678,000
Q2 2023

Jul 24, 2023

BUY
$36.12 - $41.79 $1.12 Million - $1.3 Million
31,042 New
31,042 $1.14 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Prossimo Advisors, LLC Portfolio

Follow Prossimo Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prossimo Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prossimo Advisors, LLC with notifications on news.